Enanta Announces U.S. Food and Drug Administration Approves AbbVieâs VIEKIRA PAKâ¢ (Ombitasvir/Paritaprevir/Ritonavir Tablets; Dasabuvir Tablets) for the Treatment of Chronic Genotype 1 Hepatitis C Virus